Neurodegenerative disorders, such as Alzheimer’s disease (AD) or Parkinson’s disease (PD), are accompanied by the loss of specific neurons and alterations in the conformation of proteins such as β-amyloid and tau (in AD) and α-synuclein (in PD). This evidence concerns the gene MAPT and Parkinson disease.